"The US Food and Drug Administration (FDA) today approved asfotase alfa (Strensiq, Alexion Pharmaceuticals) as the first-ever therapy for patients who develop hypophosphatasia, a rare metabolic bone disorder, in childhood.
(Generic versions may still be available.)
Metaraminol bitartrate is [R-(R*,S*)]-a-(1-aminoethyl)-3-hydroxybenzenemethanol [R-(R*, R*)]- 2,3-dihydroxybutanedioate (1:1) (salt), which is levorotatory. Its empirical formula is C9H13NO2 C4H6O6 , and its structural formula is:
Injection ARAMINE* (Metaraminol Bitartrate, MADE is a sterile solution. Each mL contains:
equivalent to metaraminol ....................... 10 mg
Water for Injection q.s. ad ..... 1 mL
Methylparaben 0.15%, propylparaben 0.02%, and sodium bisulfite 0.2% added as preservatives.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Aramine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.